Serosurvey for vaccine-preventable diseases among adult refugees

Serosurvey for vaccine-preventable diseases among adult refugees - Serosurvey among refugees

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43434

Enrollment

850

Registered

2016-04-06

Start date

2016-07-11

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune system protection against diseases

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The person is registered as refugee at an emergency accommodation for refugees The person is between 18 and 45 years of age The person originates from any of the following countries: Afghanistan, Iran, Iraq, Eritrea, Ethiopia, Syria The person is able to provide informed consent

Exclusion criteria

Exclusion criteria: The person refuses to participate in the study The person is unable to provide informed consent (e.g. due to language barriers)

Design outcomes

Primary

Measure	Time frame
The age-specific seroprevalence (immunity) for selected vaccine-preventable diseases among adult refugees between 18-45 years of age.	—

Secondary

Measure	Time frame
The prevalence of viral hepatitis B and C infection. The parameters tested for are: - Hepatitis B virus: Anti-HBc, HBsAg, anti-HBs, HBV-DNA (if HBsAg is positive) - Hepatitis C virus: Anti-HCV, HCV-RNA (when anti-HCV is positive)	—

Countries

Netherlands

Outcome results